In contrast, we only observed relatively low-level copy number gains and losses of KEAP1, even though a high mutation rate of KEAP1 was detected in lung adenocarcinoma (LUAD) and squamous cell carcinoma (Supplementary Figure S1A). This evidence concerns the gene KEAP1 and lung adenocarcinoma.